SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-035369
Filing Date
2019-06-13
Accepted
2019-06-13 16:37:03
Documents
7
Period of Report
2019-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-11314_28k.htm 8-K 37513
2 EX-10.1 a19-11314_2ex10d1.htm EX-10.1 407884
3 EX-10.2 a19-11314_2ex10d2.htm EX-10.2 34063
4 EX-99.1 a19-11314_2ex99d1.htm EX-99.1 10864
5 GRAPHIC g113142ks07i001.jpg GRAPHIC 36140
6 GRAPHIC g113142ks07i002.jpg GRAPHIC 33140
7 GRAPHIC g113142mmi001.jpg GRAPHIC 2840
  Complete submission text file 0001104659-19-035369.txt   591234
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 19896507
SIC: 2834 Pharmaceutical Preparations